Presentation Information

[28-26-am01S]Cardiomyocyte-specific SETD3KO suppressed the progression of heart failure and cardiomyocyte hypertrophy

○Yuto Suzuki1,2, Yoichi Sunagawa1,2,3, Ryuji Minegishi1, Haname Sekido1, Yasuhumi Katanasaka1,2,3, Koji Hasegawa1,2, Tatsuya Morimoto1,2,3,4, Tetsuya Hosooka1 (1. Division of Molecular Medicine, Grad. Sch. Pharm. Sci. University of Shizuoka, 2. Division of Translational Research, Clinical Research Institute, Kyoto Medical Center, NHO., 3. Shizuoka General Hospital., 4. Department of Pharmacology, Sch. Med., Toho Univ.)

Password required to view

Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.